The PI3K p110δ Regulates Expression of CD38 on Regulatory T Cells
Author(s) -
Daniel T. Patton,
Marcus D. Wilson,
Wendy C. Rowan,
Dalya R. Soond,
Klaus Okkenhaug
Publication year - 2011
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0017359
Subject(s) - cd38 , foxp3 , downregulation and upregulation , biology , transcriptome , il 2 receptor , regulatory t cell , microbiology and biotechnology , regulator , t cell , immunology , gene expression , gene , genetics , immune system , stem cell , cd34
The PI3K pathway has emerged as a key regulator of regulatory T cell (Treg) development and homeostasis and is required for full Treg-mediated suppression. To identify new genes involved in PI3K-dependent suppression, we compared the transcriptome of WT and p110δ D910A Tregs. Among the genes that were differentially expressed was the gene for the transmembrane cyclic ADP ribose hydrolase CD38. Here we show that CD38 is expressed mainly by a subset of Foxp3 + CD25 + CD4 + T cells originating in the thymus and on Tregs in the spleen. CD38 high WT Tregs showed superior suppressive activity to CD38 low Tregs, which failed to upregulate CD73, a surface protein which is important for suppression. However, Tregs from heterozygous CD38 +/− mice were unimpaired despite lower levels of CD38 expression. Therefore, CD38 can be used as a marker for Tregs with high suppressive activity and the impaired Treg function in p110δ D910A mice can in part be explained by the failure of CD38 high cells to develop.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom